Cat.#: ACPP-1311
| Despition | Leukemia Inhibitory Factor Human Recombinant |
| SIZE | 3 x 2 µg |
| Purity | > 98.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1275 | Usherin Blocking Peptide (AC1275) | 250 µg | inquiry |
| ACPP-1227 | Pax2 Blocking Peptide (AC1227) | 250 µg | inquiry |
| ACPP-1426 | Human ENO2 Protein (AC1426) | 5 µg | inquiry |
| ACPP-1714 | Human PGR Protein (AC1714) | 2 µg | inquiry |
| ACPP-1691 | Human MGLL Protein (AC1691) | 2 µg | inquiry |
| ACPP-1832 | Human CRYZ Protein (AC1832) | 5 µg | inquiry |
| ACPP-1792 | Rat CALB1 Protein (AC1792) | 1 µg | inquiry |
| ACPP-1740 | Human RCAN1 Protein (AC1740) | 5 µg | inquiry |
| ACPP-1071 | Visfatin Blocking Peptide (AC1071) | 250 µg | inquiry |
| ACPP-1324 | Insulin Receptor Blocking Peptide (AC1324) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.